What is VoxNeuro?
VoxNeuro operates at the intersection of neurology and software engineering, providing a sophisticated cognitive health assessment platform. By integrating established neuropsychological testing protocols with proprietary EEG-based brain performance software, the company delivers objective, data-driven scores of cognitive function. This methodology addresses a long-standing gap in clinical diagnostics, where subjective reporting has historically hindered the precision of neurological evaluations. By digitizing and standardizing these assessments, VoxNeuro enables healthcare providers to track cognitive health with unprecedented accuracy, facilitating earlier interventions and more personalized treatment plans for patients suffering from cognitive decline or neurological impairment.
How much funding has VoxNeuro raised?
VoxNeuro has raised a total of $3.4M across 1 funding round:
Other Financing Round
$3.4M
Other Financing Round (2023): $3.4M, investors not publicly disclosed
Key Investors in VoxNeuro
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for VoxNeuro?
Following this major enterprise-level funding, VoxNeuro is expected to prioritize the expansion of its clinical footprint and the refinement of its diagnostic algorithms. The strategic deployment of this capital will likely focus on scaling commercial operations, securing additional regulatory clearances, and deepening partnerships with healthcare systems that require robust, objective data to improve patient outcomes. As the demand for scalable, non-invasive brain health monitoring grows, VoxNeuro is positioned to leverage its technological advantage to capture significant market share within the global digital health landscape. Future growth will likely hinge on the company's ability to integrate its diagnostic suite into standard electronic health record systems, thereby streamlining the clinical workflow for neurologists and primary care physicians alike.
See full VoxNeuro company page
